Pre-symptomatic Caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging

Previous work showed that the caspase 1 inhibitor VX-765 rescued cognitive deficits in the J20 mouse model of Alzheimer’s disease, and this may occur via reduced inflammation. Here the authors show that administration of the drug prior to onset of cognitive deficits and pathology in mice delays the...

Full description

Bibliographic Details
Main Authors: Joseph Flores, Anastasia Noël, Bénédicte Foveau, Olivier Beauchet, Andréa C. LeBlanc
Format: Article
Language:English
Published: Nature Portfolio 2020-09-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-020-18405-9
_version_ 1818434128755818496
author Joseph Flores
Anastasia Noël
Bénédicte Foveau
Olivier Beauchet
Andréa C. LeBlanc
author_facet Joseph Flores
Anastasia Noël
Bénédicte Foveau
Olivier Beauchet
Andréa C. LeBlanc
author_sort Joseph Flores
collection DOAJ
description Previous work showed that the caspase 1 inhibitor VX-765 rescued cognitive deficits in the J20 mouse model of Alzheimer’s disease, and this may occur via reduced inflammation. Here the authors show that administration of the drug prior to onset of cognitive deficits and pathology in mice delays the onset of deficits.
first_indexed 2024-12-14T16:32:04Z
format Article
id doaj.art-f9e708e8e4a94657bdc8e388bc81fd42
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-12-14T16:32:04Z
publishDate 2020-09-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-f9e708e8e4a94657bdc8e388bc81fd422022-12-21T22:54:33ZengNature PortfolioNature Communications2041-17232020-09-0111111410.1038/s41467-020-18405-9Pre-symptomatic Caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and agingJoseph Flores0Anastasia Noël1Bénédicte Foveau2Olivier Beauchet3Andréa C. LeBlanc4Bloomfield Center for Research in Aging, Lady Davis Institute for Medical Research, Jewish General HospitalBloomfield Center for Research in Aging, Lady Davis Institute for Medical Research, Jewish General HospitalBloomfield Center for Research in Aging, Lady Davis Institute for Medical Research, Jewish General HospitalBloomfield Center for Research in Aging, Lady Davis Institute for Medical Research, Jewish General HospitalBloomfield Center for Research in Aging, Lady Davis Institute for Medical Research, Jewish General HospitalPrevious work showed that the caspase 1 inhibitor VX-765 rescued cognitive deficits in the J20 mouse model of Alzheimer’s disease, and this may occur via reduced inflammation. Here the authors show that administration of the drug prior to onset of cognitive deficits and pathology in mice delays the onset of deficits.https://doi.org/10.1038/s41467-020-18405-9
spellingShingle Joseph Flores
Anastasia Noël
Bénédicte Foveau
Olivier Beauchet
Andréa C. LeBlanc
Pre-symptomatic Caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging
Nature Communications
title Pre-symptomatic Caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging
title_full Pre-symptomatic Caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging
title_fullStr Pre-symptomatic Caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging
title_full_unstemmed Pre-symptomatic Caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging
title_short Pre-symptomatic Caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging
title_sort pre symptomatic caspase 1 inhibitor delays cognitive decline in a mouse model of alzheimer disease and aging
url https://doi.org/10.1038/s41467-020-18405-9
work_keys_str_mv AT josephflores presymptomaticcaspase1inhibitordelayscognitivedeclineinamousemodelofalzheimerdiseaseandaging
AT anastasianoel presymptomaticcaspase1inhibitordelayscognitivedeclineinamousemodelofalzheimerdiseaseandaging
AT benedictefoveau presymptomaticcaspase1inhibitordelayscognitivedeclineinamousemodelofalzheimerdiseaseandaging
AT olivierbeauchet presymptomaticcaspase1inhibitordelayscognitivedeclineinamousemodelofalzheimerdiseaseandaging
AT andreacleblanc presymptomaticcaspase1inhibitordelayscognitivedeclineinamousemodelofalzheimerdiseaseandaging